An awareness of the importance of nutritional status in hospital settings began more than 40
years ago. Much has been learned since and has altered care. For the past 40 years several …

Body composition has gained increasing attention in oncology in recent years due to fact
that sarcopenia has been revealed to be a strong prognostic indicator for survival across …

Patients with cancer are at an increased risk for muscle loss via 2 distinct mechanisms:
sarcopenia, defined as the age‐associated decrease in muscle mass related to changes in …

Evidence for a strong link between sarcopenia and chemotherapy toxicity is increasing.
SMM may not be the only body composition parameter involved. Muscle function assessed …

Body composition, defined as the proportions and distribution of lean and fat tissues in the
human body, is an emergent theme in clinical oncology. Severe muscle depletion …

Sarcopenia has recently emerged as a new condition that, independently from malnutrition,
may adversely affect the prognosis of cancer patients. Purpose of this narrative review is to …

Malnutrition is a common comorbidity in patients with cancer, with determinants linked to the
patients, the tumor, and the treatment. Cancer malnutrition, also called cachexia, represents …

Several nutritional assessment tools have been used in oncology settings to monitor
nutritional status and its associated prognostic significance. Body composition is …

Clinicians often believe that cachexia is caused by cancer and anorexia as a toxicity of
chemotherapy or targeted anti-cancer agents. It is now recognized that chemotherapy and …

The provision of additional calories and protein alone has not been shown to be efficacious
in patients with cancer cachexia. Although primary research continues to unravel the …